| HF | Heart failure |
| CVD | Cardiovascular disease |
| IHD | Ischemic heart disease |
| LVEF | Left ventricular ejection fraction |
| HFrpEF | HF with reduced ejection fraction |
| HFpEF | HF with preserved ejection fraction |
| AS | Atherosclerosis |
| SCFAs | Short-chain fatty acids |
| TMAO | Trimethylamine N-oxide |
| BAs | Bile acids |
| LPS | Lipopolysaccharide |
| TMA | Trimethylamine |
| FMOs | Flavin-containing monooxygenases |
| TMAU | Trimethylaminuria |
| HFD | High-fat diet |
| IL | Interleukin |
| NLRP3 | Nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3 |
| SIRT3 | Sirtuin 3 |
| SOD2 | Superoxide dismutase 2 |
| mtROS | Mitochondrial reactive oxygen species |
| ROS | Reactive oxygen species |
| TXNIP | Thioredoxin-interacting protein |
| TNF | Tumor necrosis factor |
| FA | Fatty acid |
| OXPHOS | Oxidative phosphorylation |
| PLIN4 | Perilipin 4 |
| OMA1 | Overlapping activity with m-AAA protease 1 |
| OGDHL | Oxoglutarate dehydrogenase L |
| BAT | Brown adipose tissue |
| CP | Creatine phosphate |
| ATP | Adenosine triphosphate |
| Ca2+ | Calcium ion |
| eNOS | Endothelial nitric oxide synthase |
| NOX2 | NADPH oxidase 2 |
| PIEZO1 | Piezo type mechanosensitive ion channel component 1 |
| WD | Western diet |
| ANP | atrial natriuretic peptide |
| β-MHC | β-myosin heavy chain |
| TGF | Transforming growth factor |
| NF | Nuclear factor |
| BNP | Brain natriuretic peptide |
| LV | Left ventricular |
| NO | Nitric oxide |
| CHF | Chronic heart failure |
| HTN | Hypertension |
| ANG | Angiotensin |
| MI | Myocardial infarction |
| RCT | Reverse cholesterol transport |
| ApoE−/− | Apolipoprotein E knockout |
| CADs | Coronary artery diseases |
| SGLT2 | Sodium-glucose cotransporter-2 |
| ACEIs | Angiotensin-converting enzyme inhibitors |
| MD | Mediterranean diet |
| MF | Multistrain formula |
| DMB | 3,3-dimethyl-1-butanol |
| FMC | Fluoromethylcholine |
| IMC | Iodomethylcholine |
| T2DM | Type 2 diabetes mellitus |
| ASCVD | Atherosclerotic cardiovascular disease |
| ARBs | Angiotensin receptor blockers |
| ARNIs | Angiotensin receptor–neprilysin inhibitors |
| BBR | Berberine |
| RES | Resveratrol |
| GYP | Gypenosides |
| LBPs | Lycium barbarum polysaccharides |
| PU | Puerarin |
| PMFs | Polymethoxyflavones |